Navigation Links
Dr. DeLuca of Kessler Foundation speaks at Consortium of MS Centers meeting in Chicago
Date:4/10/2013

West Orange, NJ. April 10, 2013. John DeLuca, PhD, VP of Research & Training at Kessler Foundation, will speak at the Embassy Suites Chicago Downtown-Lakefront in Chicago, Illinois, on April 26, 2013. This one-day CME-accredited program, "Assessing and Managing Neuropsychiatric Problems in Multiple Sclerosis (MS): From MRI to Treatment" is chaired by Ralph Benedict, PhD, and hosted by the Consortium of MS Centers (CMSC). Organized in 1986 under the direction of neurologists interested in the clinical care of MS, CMSC has grown to become a multi-disciplinary organization providing a team approach to MS care and a network for all health care professionals and others specializing in the care of persons with MS.

The educational needs of healthcare professionals working with patients with MS include knowledge of cognitive impairment, which may be mild, moderate, or severe. Dr. DeLuca, an expert in cognitive rehabilitation research, will address "Behavioral Approaches to Cognitive Rehabilitation in Multiple Sclerosis." The program faculty includes Fred Foley, PhD, Robert Zivadinov, MD, PhD, Anthony Feinstein, MD, PhD, and Sarah Morrow, MD, FRCPC, MS.

Registration deadline is April 17.

To register: http://www.mscare.org/events/event_details.asp?id=293444&group= For more information, contact education@mscare.org

About John DeLuca

Dr. DeLuca is VP of Research & Training at Kessler Foundation, which conducts cognitive and physical research in brain injury (TBI), multiple sclerosis, spinal cord injury, and stroke. He specializes in the study of disorders of memory and information processing in TBI and MS and has published more than 200 articles, books, and chapters in these areas. His collaborative work in cognitive rehabilitation extends to Italy, Spain, Portugal, and China. He has obtained more than $26 million in grant funding and is the editor/co-editor of five recent books, including the Encyclopedia of Clinical Neuropsychology, the first encyclopedia of its kind. Dr. DeLuca often presents at national and international conferences and contributes to continuing education for professionals and consumers. He is a professor in the Departments of Physical Medicine & Rehabilitation and Neurology & Neurosciences at University of Medicine and Dentistry of New Jersey-New Jersey Medical School, and a licensed psychologist in the states of New Jersey and New York.

Recent articles:

Chiaravalloti ND, Wylie G, Leavitt V, Deluca J (2012) Increased cerebral activation after behavioral treatment for memory deficits in MS. Journal of Neurology. DOI: 10.1007/s00415-011-6353-x.

Sumowski, J.F., Wylie, G.R., Leavitt, V.M., Chiaravalloti N.D., DeLuca J. (2013). Default network activity is a sensitive and specific biomarker of memory in MS. Multiple Sclerosis Journal, 19, 199-208.

DeLuca, J. & Nocentini, U. (2011). Neuropsychological, medical and rehabilitative management of persons with multiple sclerosis. NeuroRehabilitation, 29, 197-219.


'/>"/>

Contact: Carolann Murphy
CMurphy@kesslerfoundation.org
973-324-8382
Kessler Foundation
Source:Eurekalert

Related medicine news :

1. DeLuca of Kessler Foundation receives research award from American Psychological Association
2. Dr. Deluca of Kessler Foundation receives medical excellence award for MS research
3. John DeLuca, Ph.D., of Kessler Foundation delivers keynote at IPMSC meeting in Milan
4. Kessler Foundation names Dr. John Whyte recipient of Foundations 2nd Annual DeLisa Award
5. Kessler Foundation scientist awarded $554,000 for multiple sclerosis employment research
6. Kessler Foundation researchers present at first International Congress on Cognition in MS
7. Kessler Foundation scientists present cognitive research findings at MS dual symposium
8. Kessler Foundations A.M. Barrett appointed to National Quality Forum Steering Committee
9. Kessler Foundation and Heldrich Center issue brief on hiring workers with disabilities
10. Kessler Foundation presents Brain Injury: From Research to Rebuilding Lives on Sept. 27-28
11. Dr. Chiaravalloti of Kessler Foundation comments on trends in rehabilitation research in MS
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... , ... October 13, 2017 , ... The American Board ... become its next President and Chief Executive Officer, succeeding Dr. James C. Puffer upon ... beginning July 1, 2018 until Dr. Puffer’s retirement at the end of 2018. Upon ...
(Date:10/13/2017)... ... October 13, 2017 , ... Lori R. Somekh, founder of the ... national organization of elder law and special needs planning attorneys. “Membership in ElderCounsel helps ... provides a forum to network with elder law attorneys nationwide,” said Somekh. , ...
(Date:10/13/2017)... ... October 13, 2017 , ... Ellevate Network, the leading ... to advocate for action towards gender equality at their inaugural Summit in New York ... globe, and reached a social audience of over 3 million. To watch the Mobilize ...
(Date:10/13/2017)... ... October 13, 2017 , ... Coveros, a ... has been awarded a contract by the Center for Medicare and Medicaid Services ... accelerate the enterprise use of Agile methodologies in a consistent and high value ...
(Date:10/12/2017)... Francisco, CA (PRWEB) , ... October 12, 2017 ... ... Dr. Cheng, are now treating sleep apnea using cutting-edge Oventus O2Vent ... apnea, a serious sleep disorder characterized by frequent cessation in breathing. Oral appliances ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... , Oct. 2, 2017  AllianceRx Walgreens Prime, ... formed by Walgreens and pharmacy benefit manager Prime Therapeutics ... new brand, which included the unveiling of new signage ... , as well as at a few other company-owned ... new brand to patients, some of whom will begin ...
(Date:9/28/2017)... 2017 Cohen Veterans Bioscience and Early Signal ... wearable and home sensors for real-time monitoring of patients ... a nonprofit organization focused on disruptive health solutions for ... analytical system to record and integrate behavioral, cognitive, physiological ... ...
(Date:9/25/2017)... PROVIDENCE, R.I. , Sept. 25, 2017 /PRNewswire/ ... immunogenicity assessment, vaccine design, and immune-engineering today announced ... focused on the development of personalized therapeutic cancer ... and has provided exclusive access to enabling technologies ... MSc Eng., MBA will lead EpiVax Oncology as ...
Breaking Medicine Technology: